[go: up one dir, main page]

IE872951L - Composition for use in hypertension - Google Patents

Composition for use in hypertension

Info

Publication number
IE872951L
IE872951L IE872951A IE295187A IE872951L IE 872951 L IE872951 L IE 872951L IE 872951 A IE872951 A IE 872951A IE 295187 A IE295187 A IE 295187A IE 872951 L IE872951 L IE 872951L
Authority
IE
Ireland
Prior art keywords
hypertension
composition
ca1314222c
dithia
azaspiro
Prior art date
Application number
IE872951A
Other versions
IE60496B1 (en
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868626217A external-priority patent/GB8626217D0/en
Priority claimed from GB878713349A external-priority patent/GB8713349D0/en
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of IE872951L publication Critical patent/IE872951L/en
Publication of IE60496B1 publication Critical patent/IE60496B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A pharmaceutical composition for use against hypertension and congestive heart failure containing a) A calcium antagonist and b) the ACE-inhibitor 7-(N-¢1-(S)-Ethoxycarbonyl-3-phenylpropyl!-(S)-alanyl)-1,4-dithia-7-azaspiro-¢4,4!nonane-8-(S)-carboxylic acid. [CA1314222C]
IE295187A 1986-11-03 1987-11-02 Pharmaceutical composition for use against hypertension and congestive heart failure IE60496B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868626217A GB8626217D0 (en) 1986-11-03 1986-11-03 Pharmaceutical compositions
GB878713349A GB8713349D0 (en) 1987-06-08 1987-06-08 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
IE872951L true IE872951L (en) 1988-05-03
IE60496B1 IE60496B1 (en) 1994-07-27

Family

ID=26291485

Family Applications (1)

Application Number Title Priority Date Filing Date
IE295187A IE60496B1 (en) 1986-11-03 1987-11-02 Pharmaceutical composition for use against hypertension and congestive heart failure

Country Status (25)

Country Link
KR (1) KR960005145B1 (en)
AT (1) AT397343B (en)
AU (1) AU615883B2 (en)
BE (1) BE1002063A4 (en)
CA (1) CA1314222C (en)
CH (1) CH677189A5 (en)
DE (1) DE3736505A1 (en)
DK (1) DK574087A (en)
ES (1) ES2010524A6 (en)
FI (1) FI874823A7 (en)
FR (1) FR2605885B1 (en)
GR (1) GR871680B (en)
HK (1) HK138893A (en)
HU (1) HU199681B (en)
IE (1) IE60496B1 (en)
IL (1) IL84343A (en)
IT (1) IT1212037B (en)
LU (1) LU87034A1 (en)
MY (1) MY102124A (en)
NL (1) NL8702502A (en)
NO (1) NO874539L (en)
NZ (1) NZ222401A (en)
PH (1) PH23249A (en)
PT (1) PT86062B (en)
SE (1) SE8704272L (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3818245A1 (en) * 1988-05-28 1989-12-07 Hoechst Ag COMBINATION OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS WITH COLD CHANNEL MODULATORS AND THEIR USE IN MEDICINAL PRODUCTS
FR2733911B1 (en) * 1995-05-09 1998-05-29 Takeda Chemical Industries Ltd PHARMACEUTICAL COMPOSITION FOR RENAL OR CARDIOVASCULAR DISEASES

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4470972A (en) * 1981-04-28 1984-09-11 Schering Corporation 7-Carboxyalkylaminoacyl-1,4-dithia-7-azaspiro[4.4]-nonane-8-carboxylic acids
US4520021A (en) * 1982-07-02 1985-05-28 Merck & Co., Inc. Substituted caprolactam derivatives as antihypertensives
DE3437917A1 (en) * 1984-10-17 1986-04-17 Bayer Ag, 5090 Leverkusen COMBINATION OF DIHYDROPYRIDINE WITH ACE INHIBITORS AND THEIR USE IN MEDICINAL PRODUCTS
DE3633496A1 (en) * 1986-10-02 1988-04-14 Hoechst Ag COMBINATION OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS WITH CALCIUMANTAGONISTS AND THEIR USE IN MEDICINAL PRODUCTS
GB2198641B (en) * 1986-11-03 1990-09-19 Sandoz Ltd Pharmaceutical composition for use against hypertension and congestive heart failure
IL88502A (en) * 1987-12-14 1993-04-04 Squibb & Sons Inc Pharmaceutical compositions containing an angiotensin converting enzyme inhibitor

Also Published As

Publication number Publication date
FI874823A0 (en) 1987-11-02
IT8748553A0 (en) 1987-10-30
DE3736505A1 (en) 1988-05-05
MY102124A (en) 1992-03-31
SE8704272D0 (en) 1987-11-02
IL84343A (en) 1993-07-08
ATA286987A (en) 1993-08-15
AU8057687A (en) 1988-05-05
IL84343A0 (en) 1990-02-09
KR960005145B1 (en) 1996-04-22
SE8704272L (en) 1988-05-04
AU615883B2 (en) 1991-10-17
NZ222401A (en) 1991-04-26
PT86062B (en) 1990-11-07
FR2605885B1 (en) 1993-09-10
IT1212037B (en) 1989-11-08
HUT47847A (en) 1989-04-28
NL8702502A (en) 1988-06-01
BE1002063A4 (en) 1990-06-12
ES2010524A6 (en) 1989-11-16
IE60496B1 (en) 1994-07-27
CA1314222C (en) 1993-03-09
FI874823L (en) 1988-05-04
PT86062A (en) 1987-12-01
GR871680B (en) 1988-05-02
HK138893A (en) 1993-12-24
FR2605885A1 (en) 1988-05-06
KR880006197A (en) 1988-07-22
LU87034A1 (en) 1988-05-03
NO874539D0 (en) 1987-11-02
AT397343B (en) 1994-03-25
FI874823A7 (en) 1988-05-04
DK574087D0 (en) 1987-11-02
DK574087A (en) 1988-05-04
NO874539L (en) 1988-05-04
HU199681B (en) 1990-03-28
PH23249A (en) 1989-06-16
CH677189A5 (en) 1991-04-30

Similar Documents

Publication Publication Date Title
BG103143A (en) Substituted pyrido- or pirimidocontaining 6,6- or 6,7-bicyclic derivatives
AU2965889A (en) 3 (3-indoyl) pyrrole-2,5-dione derivatives
NZ229480A (en) Amino acid derivatives containing nitrogen-containing heterocycle, and pharmaceutical compositions
BG103192A (en) Substituted 6,6-hetero-bicyclic derivatives
EP0300189A3 (en) New amino acid derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
EP0336760A3 (en) Bone-inducing protein
AU2974189A (en) Pharmaceutical compositions containing lactams, new substituted lactams and processes for the preparation thereof
CA2215234A1 (en) Composition containing amlodipine, or its salt and an ace inhibitor
GB2190677B (en) 1-(hydroxystyryl)-5h-2,3-benzodiazepine derivatives, process for the preparation thereof and pharmaceutical compositions containing the same
CA2238389A1 (en) Novel geranylgeranyl-derivatives, process for the preparation thereof and related pharmaceutical compositions
AU576550B2 (en) Substituted hexahydro arylquinolizines
IE872951L (en) Composition for use in hypertension
AU574978B2 (en) Method for treatment of antidiuresis employing serine derivatives
EP0226312A3 (en) Treating increased intraocular pressure by steroids
AU1939488A (en) Method and compositions for making ACSF and ACSF antagonists
IE813100L (en) Naphthyridine derivatives
EP0317279A3 (en) Peptides for use in the purification of factor viii
IE840977L (en) Pharmaceutical preparations
IE812399L (en) Benzodioxines
AR243159A1 (en) Procedure for the preparation of 1-(3-mercaptan-(2s)-methylpropionyl)-pyrolidine-(2s)-carb<543>oxylic acid or its pharmaceutically acceptable salts.
AU3952189A (en) Novel derivatives of 6,11-dihydro-dibenzo (c.f.) (1,2,5) -thiadiazepine 5,5-dioxide, salts therof and appropriate processes for the preparation therof
AU3597289A (en) D-cys6 vasopressin antagonists
IE872614L (en) Pharmaceutical composition for the treatment of high blood¹pressure
GB9014705D0 (en) Pharmaceutical composition for use against hypertension and congestive heart failure
ZA878256B (en) Pharmaceutical composition for use against hypertension and congestive heart failure

Legal Events

Date Code Title Description
MM4A Patent lapsed